Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.
The Food and Drug Administration has issued an alert concerning two glucose monitors with a “high-risk” sensor issue. Abbott Diabetes Care initiated a “medical device correction” on Nov. 24, for ...
Abbott Diabetes Care has alerted patients that the FreeStyle Libre 3 and Libre 3 Plus glucose sensors may provide incorrect low glucose readings. The FDA posted an Early Alert about the issue on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback